The R-Pharm Group of Companies is the largest Russian manufacturer of medicines.

In 2021, the release of a vaccine against the new coronavirus infection COVID-19 was launched.

There are 4 R-Pharm sites in the Yaroslavl region:

• Yaroslavl Factory of Ready-made Dosage Forms
• Pharmoslavl
• R-Pharm-Novoselki
• R-Pharm Progress

Yaroslavl production is one of the few in Russia where the production of monoclonal antibodies has been established – active substances of a biological nature used to treat many socially significant diseases.

The company is an active recipient of government support measures

• tax benefits of a priority investment project (PIP YAO)
• The Federal Agreement on the Protection and Promotion of Capital Investments (NWPC) has been concluded